AVIR - Atea Pharmaceuticals GAAP EPS of -$0.34 beats by $0.15
2023-08-08 17:49:56 ET
- Atea Pharmaceuticals press release ( NASDAQ: AVIR ): Q2 GAAP EPS of -$0.34 beats by $0.15 .
-
Cash, Cash Equivalents and Marketable Securities: $608.1 million at June 30, 2023 compared to $646.7 million at December 31, 2022.
-
For further details see:
Atea Pharmaceuticals GAAP EPS of -$0.34 beats by $0.15